Hitting Pause on the J&J Vaccine

The diabetes drugs that transformed weight loss may be key to treating addiction, too. Dr. Sanjay Gupta speaks with Dr. Dhruv Khullar about how GLP-1s affect the brain, its reward system, and maybe even addiction. This episode was produced by Jennifer Lai with assistance from Sof ...  Show more

An FDA panel has recommended allowing compounding pharmacies to make six unapproved peptides. Dr. Sanjay Gupta and CNN Health's John Bonifield discuss their popularity, safety concerns and what comes next. This episode was produced by Madeleine Thompson and Leying Tang. Medical W ...  Show more

After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ...  Show more

The Centers for Disease Control and Prevention and the Food and Drug Administration announced a recommended pause in use of Johnson & Johnson's single-use COVID-19 vaccine, while the agencies investigate reports of a rare but serious blood clot in six people. The pause comes at a ...  Show more

Federal health agencies on Tuesday called for a pause in the use of Johnson & Johnson’s coronavirus shot as they examine a rare blood-clotting disorder that emerged in six recipients.

Every state, the District of Columbia and Puerto Rico halted their rollout of the Johns ...

The FDA vaccine advisers recommended authorization of Johnson & Johnson’s coronavirus vaccine. In the U.S., the single-shot showed an overall efficacy of 72% in preventing moderate to severe disease and 85% effective in preventing severe disease. CNN’s Chief Medical Correspondent ...  Show more